Hi M, nice to see a friendly follower of the Israel-Medical-Healthcare such as yourself :-) I sold the remaining of my Bioline shares when the stock jumped (unjustifiably imo on the HCV program) earlier this year and have not followed closely since, and anyway the Celiac Disease program is just entering the clinic.
News 
Market Data 
Discover 
